Clinical effects and bronchoalveolar transfer of levofloxacin in patients with community-acquired pneumonia
摘要篇首:To evaluate the clinical effects and bronchoalveolar transfer of levofloxacin (LVFX) in patients with community-acquired pneumonia. Twenty-eight outpatients with community-acquired pneumonia (CAP) were observed in an open-label, noncomparative study. The concentrations of levofloxacin in serum and bronchoalveolar lavage fluid (BALF) were measured by high-performance liquid chromatography (HPLC) with fluorescence detection in 10 patients and 15 non-levofloxacin users.
更多相关知识
- 浏览59
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文